Removal of cationic dye methylene blue by zero-valent iron: Effects of pH and dissolved oxygen on removal mechanisms.

Effects of pH and dissolved oxygen on mechanisms for decolorization and total organic carbon (TOC) removal of cationic dye methylene blue (MB) by zero-valent iron (ZVI) were systematically examined. Decolorization and TOC removal of MB by ZVI are attributed to the four potential mechanisms, i.e. reduction, degradation, precipitation and adsorption. The contributions of four mechanisms were quantified at pH 3.0, 6.0 and 10.0 in the oxic and anoxic systems. The maximum efficiencies of decolorization and TOC removal of MB were found at pH 6.0. The TOC removal efficiencies at pH 3.0 and 10.0 were 11.0 and 17.0%, respectively which were considerably lower as compared with 68.1% at pH 6.0. The adsorption, which was favorable at higher pH but was depressed by the passive layer formed on the ZVI surface at alkaline conditions, characterized the effects of pH on decolorization and TOC removal of MB. The efficiencies of decolorization and TOC removal at pH 6.0 under the anoxic condition were 73.0 and 59.0%, respectively, which were comparable to 79.9 and 55.5% obtained under the oxic condition. In the oxic and anoxic conditions, however, the contributions of removal mechanisms were quite different. Although the adsorption dominated the decolorization and TOC removal under the oxic condition, the contribution of precipitation was largely superior to that of adsorption under the anoxic condition.

Potential of atelocollagen-mediated systemic antisense therapeutics for inflammatory disease.

To study the possibility of using atelocollagen as an oligonucleotide (ODN) delivery carrier in vivo, the activity of formulated antisense ODN targeted against the intercellular adhesion molecule-1 (ICAM-1) mRNA was investigated in an allergic dermatitis model in mice. The allergic dermatitis was elicited in one ear of animals sensitized by treatment with 2,4-dinitrofluorobenzene. Antisense ODN was given to the animals as a single intravenous injection of formulation containing atelocollagen. Antisense activity was determined by measurement of ear thickness, histopathology, and immunohistochemistry 24 hr after the initiation of the dermatitis. Antisense activity was found to increase according to the concentration of atelocollagen in the formulation. The effect mediated by the ODN formulated with 0.05% atelocollagen was more than 50 times greater than that provided by ODN infusion, although the levels of ODN formulated with atelocollagen dropped below that of the 24-hr infusion group within 30 min. The formulated ODN could suppress inflammatory progression by treatment at 8 hr after the ear challenge when inflammation had already commenced at the challenged site. Moreover, antisense activity was noted even when the formulated ODN was injected 3 days before the initiation of inflammation. These data demonstrate that atelocollagen can enhance antisense activity remarkably and that the sustainable antisense activity mediated by the formulation of ODN with atelocollagen could completely change the strategy of antisense therapeutics.